Vredenburgh JJ - Search Results

1

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Wagner M, Bigner DD, Friedman AH, Friedman HS. Vredenburgh JJ, et al. Clin Cancer Res. 2007 Feb 15;13(4):1253-9. doi: 10.1158/1078-0432.CCR-06-2309. Clin Cancer Res. 2007. PMID: 17317837 Clinical Trial.

2

The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer.

Marks LB, Rosner GL, Prosnitz LR, Ross M, Vredenburgh JJ, Peters WP. Marks LB, et al. Among authors: vredenburgh jj. Cancer. 1994 Dec 1;74(11):2964-71. doi: 10.1002/1097-0142(19941201)74:11<2964::aid-cncr2820741112>3.0.co;2-x. Cancer. 1994. PMID: 7954260

3

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC Jr, Jones R, Shpall E, et al. Peters WP, et al. Among authors: vredenburgh jj. J Clin Oncol. 1993 Jun;11(6):1132-43. doi: 10.1200/JCO.1993.11.6.1132. J Clin Oncol. 1993. PMID: 8501500 Clinical Trial.

4

Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique.

Tyer CL, Vredenburgh JJ, Heimer M, Peters WP, Bast RC Jr. Tyer CL, et al. Among authors: vredenburgh jj. Clin Cancer Res. 1996 Jan;2(1):81-6. Clin Cancer Res. 1996. PMID: 9816094

5

Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescue.

Carter DL, Marks LB, Bean JM, Broadwater G, Hussein A, Vredenburgh JJ, Peters WP, Prosnitz LR. Carter DL, et al. Among authors: vredenburgh jj. J Clin Oncol. 1999 Mar;17(3):887-93. doi: 10.1200/JCO.1999.17.3.887. J Clin Oncol. 1999. PMID: 10071280 Clinical Trial.

6

Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.

Rizzieri DA, Vredenburgh JJ, Jones R, Ross M, Shpall EJ, Hussein A, Broadwater G, Berry D, Petros WP, Gilbert C, Affronti ML, Coniglio D, Rubin P, Elkordy M, Long GD, Chao NJ, Peters WP. Rizzieri DA, et al. Among authors: vredenburgh jj. J Clin Oncol. 1999 Oct;17(10):3064-74. doi: 10.1200/JCO.1999.17.10.3064. J Clin Oncol. 1999. PMID: 10506601 Clinical Trial.

7

Thymic hyperplasia after high-dose chemotherapy and autologous stem cell transplantation: incidence and significance in patients with breast cancer.

Hara M, McAdams HP, Vredenburgh JJ, Herndon JE, Patz EF Jr. Hara M, et al. Among authors: vredenburgh jj. AJR Am J Roentgenol. 1999 Nov;173(5):1341-4. doi: 10.2214/ajr.173.5.10541115. AJR Am J Roentgenol. 1999. PMID: 10541115

8

Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.

Petros WP, Broadwater G, Berry D, Jones RB, Vredenburgh JJ, Gilbert CJ, Gibbs JP, Colvin OM, Peters WP. Petros WP, et al. Among authors: vredenburgh jj. Clin Cancer Res. 2002 Mar;8(3):698-705. Clin Cancer Res. 2002. PMID: 11895898 Clinical Trial.

9

Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.

Lind PA, Marks LB, Jamieson TA, Carter DL, Vredenburgh JJ, Folz RJ, Prosnitz LR. Lind PA, et al. Among authors: vredenburgh jj. Cancer. 2002 Jun 1;94(11):2821-9. doi: 10.1002/cncr.10573. Cancer. 2002. PMID: 12115368 Free article. Review.

10

Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.

Rizzieri DA, Ibom VK, Moore JO, DeCastro CM, Rosner GL, Adams DJ, Foster T, Payne N, Thompson M, Vredenburgh JJ, Gasparetto C, Long GD, Chao NJ, Gockerman JP. Rizzieri DA, et al. Among authors: vredenburgh jj. Clin Cancer Res. 2003 Feb;9(2):663-8. Clin Cancer Res. 2003. PMID: 12576433 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page